Joseph S. Driscoll
Net Worth
Last updated:
What is Joseph S. Driscoll net worth?
The estimated net worth of Mr. Joseph S. Driscoll is at least $1,291,503 as of 22 Dec 2022. He owns shares worth $16,124 as insider, has earned $181,519 from insider trading and has received compensation worth at least $1,093,860 in Akoya Biosciences, Inc..
What is the salary of Joseph S. Driscoll?
Mr. Joseph S. Driscoll salary is $364,620 per year as Chief Financial Officer in Akoya Biosciences, Inc..
How old is Joseph S. Driscoll?
Mr. Joseph S. Driscoll is 60 years old, born in 1965.
What stocks does Joseph S. Driscoll currently own?
As insider, Mr. Joseph S. Driscoll owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Akoya Biosciences, Inc. (AKYA) | Chief Financial Officer | 12,500 | $1.29 | $16,124 |
What does Akoya Biosciences, Inc. do?
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Joseph S. Driscoll insider trading
Akoya Biosciences, Inc.
Mr. Joseph S. Driscoll has made only one insider trade in 2022, according to the Form 4 filled with the SEC.
As of 22 Dec 2022 he still owns at least 12,500 units of AKYA stock.
Akoya Biosciences key executives
Akoya Biosciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Niro Ramachandran Ph.D. (50) Chief Bus. Officer
- Mr. Brian McKelligon (56) Pres, Chief Executive Officer & Director
- Mr. Joseph S. Driscoll (60) Chief Financial Officer